Bioliberty
PrivateLast Round
Seed Round
Aug 27, 2026
Total Funding Raised
$5.4M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Bioliberty is a medical technology company that develops soft robotic wearables and a digital therapy platform to assist with patient recovery from mobility-limiting conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioliberty Comparables
Compare Bioliberty with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zunosaki Limited | 86% | |
| Bioservo Technologies AB | 84% | |
| Syrebo | 82% |
Bioliberty Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 27, 2026 | ||||
| Series A | Mar 18, 2026 | ||||
| Pre Seed | Jul 1, 2025 | ||||
| Grant | Dec 4, 2023 | ||||
| Seed | Apr 4, 2023 | ||||
Grant | Dec 8, 2022 |
Key People
Founding team and executive leadership
Bioliberty Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| Scottish EDGE | Grant |
| Innovate UK | Grant |
| Old College Capital | Pre Seed, Seed, Series A |
| Scottish National Investment Bank | Series A |
| Archangel Investors | Pre Seed, Series A, Seed |
| Eos Advisory | Pre Seed, Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2026
Raised $3M in a Seed Round.
- Mar 18, 2026
$8.27M round completed.
Recent news
Latest coverage and updates
- receives_financingAug 24, 2026
Bioliberty, Inc. received financing of $4.09M in Series A on Jul 1st '25.
Bioliberty Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bioliberty's valuation, stock price, and market status.
Is Bioliberty a public or private company?
Bioliberty is a private company.
What is the current stock price of Bioliberty?
Bioliberty is a private company with no public stock price. No recent secondary market data is available.
How much is Bioliberty worth (valuation)?
Valuation information for Bioliberty is not publicly available.
Can I buy Bioliberty stock?
Bioliberty shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Bioliberty's last funding round?
Bioliberty's most recent funding round was Series A on March 19, 2026.
Who are the main investors in Bioliberty?
Key investors in Bioliberty include Scottish National Investment Bank, Archangel Investors.
Will Bioliberty IPO soon?
No public IPO plans have been announced for Bioliberty.
How can I track Bioliberty secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bioliberty's secondary market activity and sign up for updates.